- Status:
- Topic selection
- Technology type:
- Medicine
- Decision:
- Not selected
- Reason for decision:
- Not eligible for Health Technology Evaluation guidance
- Further information:
- Following information received from the company that the extension to their marketing authorisation for semaglutide will not add a significant new therapeutic indication. This technology does not meet the eligibility criteria for selection for technology appraisal and will subsequently be removed from the work programme.
- ID number:
- 11788
Project Team
- Project lead
- Abigail Stephens
Email enquiries
If you have any queries please email [email protected]
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 06 March 2023 | Topic selection. Changed as now not selected |
| 09 January 2023 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
For further information on how we select topics for development, please see our page about prioritising our guidance topics